Marker Therapeutics, Inc.
Data quality: 83%
MRKR
NASDAQ
Manufacturing
Chemicals
$1.67
▲
$0.06
(3.73%)
6 months return
—
Momentum
Neutral
ROE
-84.24%
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-84.24%
Below sector avg (-54.68%)
ROIC-70.52%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio6.50
Interest CoverageN/A
Valuation
PE (TTM|NTM)
-1.86 | -8.32
Below sector avg (-1.49)
P/B Ratio1.23
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Negative free cash flow of -12.01 M
Price History
Financial Trends
Analyst Price Target
3 analysts
Buy
+371.1%
upside to target
Current
$1.67
Consensus Target
$7.87
$5.60
Low
$10.00
High
Forecast
Forward P/E
-8.32
Forward EPS
-$0.19
Est. Revenue
20.05 M
Earnings Surprises
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -$0.19
·
Rev Est: 682,000.0
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -$0.40 | -$0.29 | -$0.12 | -$0.04 | — | — |
| Estimate | -$0.66 | -$0.27 | -$0.21 | -$0.19 | -$0.19 | -$0.18 |
| Surprise | +39.39% | -7.41% | +42.86% | +78.95% | — | — |
Growth
Rev 5Y: N/A · Earnings 1Y: N/A
Growth
Rev 5Y: N/A · Earnings 1Y: N/A| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
Profitability
ROE: -84.24% · Net Margin: N/A
Profitability
ROE: -84.24% · Net Margin: N/A| Revenue (TTM) | N/A | Net Income (TTM) | -12.16 M |
| ROE | -84.24% | ROA | -66.65% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -12.01 M |
| ROIC | -70.52% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 6.50
Safety
D/E: N/A · Current: 6.50| Debt / Equity | N/A | Current Ratio | 6.50 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 18.39 M | Tangible Book Value | 18.39 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -1.86 · EV/EBITDA: N/A
Valuation
P/E: -1.86 · EV/EBITDA: N/A| P/E Ratio | -1.86 | Forward P/E | -8.32 |
| P/B Ratio | 1.23 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 1.13 | Fwd Earnings Yield | N/A |
| FCF Yield | -53.06% | ||
| Market Cap | 22.64 M | Enterprise Value | 5.05 M |
Per Share
EPS: -0.79 · FCF/Share: -0.93
Per Share
EPS: -0.79 · FCF/Share: -0.93| EPS (Diluted TTM) | -0.79 | Revenue / Share | N/A |
| FCF / Share | -0.93 | OCF / Share | -0.93 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 98.77% · CapEx/Rev: N/A
Efficiency
FCF Conv: 98.77% · CapEx/Rev: N/A| CapEx / Revenue | N/A | FCF Conversion | 98.77% |
| SBC-Adj. FCF | -12.49 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 0.0 |
| Net Income | -12.16 M | -10.73 M | -8.24 M | -29.93 M | -41.88 M |
| EPS (Diluted) | -0.79 | -1.19 | -0.94 | -3.58 | -0.55 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -12.89 M | -11.12 M | -14.58 M | -29.95 M | -39.48 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 11.80 M | 13.47 M | 10.42 M | 26.14 M | 27.79 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | 2.79 M | 2.15 M |
| Interest Expense | — | — | — | — | — |
| Income Tax | -15,156.0 | 49,953.0 | 3,675.0 | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 19.07 M | 22.02 M | 17.13 M | 34.42 M | 68.14 M |
| Total Liabilities | 2.27 M | 3.46 M | 3.07 M | 14.82 M | 24.15 M |
| Shareholders' Equity | 16.80 M | 18.56 M | 14.05 M | 19.60 M | 43.99 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 16.07 M | 19.19 M | 15.11 M | 11.78 M | 42.35 M |
| Current Assets | 19.07 M | 22.02 M | 17.13 M | 16.62 M | 45.98 M |
| Current Liabilities | 2.27 M | 3.46 M | 3.07 M | 7.78 M | 12.90 M |
Peer Comparison
vs Manufacturing sector median (1605 peers)
Compared with similar companies in Manufacturing
Peer Comparison
vs Manufacturing sector median (1605 peers) Compared with similar companies in Manufacturing| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -1.9 | -1.5 |
| P/B | 1.2 | 1.6 |
| ROE % | -84.2 | -54.7 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.7 |
| D/E | — | 0.3 |
{"event":"ticker_viewed","properties":{"ticker":"MRKR","listing_kind":"stock","pathname":"/stocks/mrkr","exchange":"NASDAQ","country":"US"}}